117 related articles for article (PubMed ID: 20655903)
1. RhoA/Rho kinase signaling in the spinal cord and diabetic painful neuropathy.
Ohsawa M; Kamei J
Eur J Pharmacol; 2010 Oct; 644(1-3):1-4. PubMed ID: 20655903
[TBL] [Abstract][Full Text] [Related]
2. RhoA/Rho-kinase contribute to the pathogenesis of diabetic renal disease.
Peng F; Wu D; Gao B; Ingram AJ; Zhang B; Chorneyko K; McKenzie R; Krepinsky JC
Diabetes; 2008 Jun; 57(6):1683-92. PubMed ID: 18356410
[TBL] [Abstract][Full Text] [Related]
3. RhoA/Rho kinase pathway contributes to the pathogenesis of thermal hyperalgesia in diabetic mice.
Ohsawa M; Aasato M; Hayashi SS; Kamei J
Pain; 2011 Jan; 152(1):114-122. PubMed ID: 20980102
[TBL] [Abstract][Full Text] [Related]
4. Activation of RhoA/ROCK regulates NF-κB signaling pathway in experimental diabetic nephropathy.
Xie X; Peng J; Chang X; Huang K; Huang J; Wang S; Shen X; Liu P; Huang H
Mol Cell Endocrinol; 2013 Apr; 369(1-2):86-97. PubMed ID: 23376009
[TBL] [Abstract][Full Text] [Related]
5. [Relationship between RhoA/Rho-kinase signaling pathway and penile erection].
Zhu PY; Jiang R
Zhonghua Nan Ke Xue; 2008 Feb; 14(2):155-8. PubMed ID: 18390182
[TBL] [Abstract][Full Text] [Related]
6. Targeting of RhoA/ROCK signaling ameliorates progression of diabetic nephropathy independent of glucose control.
Kolavennu V; Zeng L; Peng H; Wang Y; Danesh FR
Diabetes; 2008 Mar; 57(3):714-23. PubMed ID: 18083785
[TBL] [Abstract][Full Text] [Related]
7. Role of inducible nitric oxide synthase in induction of RhoA expression in hearts from diabetic rats.
Soliman H; Craig GP; Nagareddy P; Yuen VG; Lin G; Kumar U; McNeill JH; Macleod KM
Cardiovasc Res; 2008 Jul; 79(2):322-30. PubMed ID: 18411229
[TBL] [Abstract][Full Text] [Related]
8. RhoE stimulates neurite-like outgrowth in PC12 cells through inhibition of the RhoA/ROCK-I signalling.
Talens-Visconti R; Peris B; Guerri C; Guasch RM
J Neurochem; 2010 Feb; 112(4):1074-87. PubMed ID: 19968760
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of RhoA/Rho-kinase pathway suppresses the expression of type I collagen induced by TGF-beta2 in human retinal pigment epithelial cells.
Itoh Y; Kimoto K; Imaizumi M; Nakatsuka K
Exp Eye Res; 2007 Mar; 84(3):464-72. PubMed ID: 17217948
[TBL] [Abstract][Full Text] [Related]
10. Activation of dorsal horn microglia contributes to diabetes-induced tactile allodynia via extracellular signal-regulated protein kinase signaling.
Tsuda M; Ueno H; Kataoka A; Tozaki-Saitoh H; Inoue K
Glia; 2008 Mar; 56(4):378-86. PubMed ID: 18186080
[TBL] [Abstract][Full Text] [Related]
11. RhoA/Rho-kinase in erectile tissue: mechanisms of disease and therapeutic insights.
Jin L; Burnett AL
Clin Sci (Lond); 2006 Feb; 110(2):153-65. PubMed ID: 16411892
[TBL] [Abstract][Full Text] [Related]
12. Statins may ameliorate pulmonary hypertension via RhoA/Rho-kinase signaling pathway.
Xing XQ; Gan Y; Wu SJ; Chen P; Zhou R; Xiang XD
Med Hypotheses; 2007; 68(5):1108-13. PubMed ID: 17097823
[TBL] [Abstract][Full Text] [Related]
13. Spinal RhoA/Rho kinase signalling pathway may participate in the development of bone cancer pain.
Hang LH; Shao DH; Chen Z; Sun WJ
Basic Clin Pharmacol Toxicol; 2013 Aug; 113(2):87-91. PubMed ID: 23521814
[TBL] [Abstract][Full Text] [Related]
14. Lesional RhoA+ cell numbers are suppressed by anti-inflammatory, cyclooxygenase-inhibiting treatment following subacute spinal cord injury.
Schwab JM; Conrad S; Elbert T; Trautmann K; Meyermann R; Schluesener HJ
Glia; 2004 Sep; 47(4):377-86. PubMed ID: 15293235
[TBL] [Abstract][Full Text] [Related]
15. RhoA/Rho kinase: a novel therapeutic target in diabetic complications.
Zhou H; Li YJ
Chin Med J (Engl); 2010 Sep; 123(17):2461-6. PubMed ID: 21034566
[TBL] [Abstract][Full Text] [Related]
16. Diabetes-induced mechanical hyperalgesia involves spinal mitogen-activated protein kinase activation in neurons and microglia via N-methyl-D-aspartate-dependent mechanisms.
Daulhac L; Mallet C; Courteix C; Etienne M; Duroux E; Privat AM; Eschalier A; Fialip J
Mol Pharmacol; 2006 Oct; 70(4):1246-54. PubMed ID: 16868181
[TBL] [Abstract][Full Text] [Related]
17. Actin cytoskeleton dynamics promotes leptin-induced vascular smooth muscle hypertrophy via RhoA/ROCK- and phosphatidylinositol 3-kinase/protein kinase B-dependent pathways.
Zeidan A; Paylor B; Steinhoff KJ; Javadov S; Rajapurohitam V; Chakrabarti S; Karmazyn M
J Pharmacol Exp Ther; 2007 Sep; 322(3):1110-6. PubMed ID: 17562852
[TBL] [Abstract][Full Text] [Related]
18. The vitamin D receptor agonist elocalcitol inhibits IL-8-dependent benign prostatic hyperplasia stromal cell proliferation and inflammatory response by targeting the RhoA/Rho kinase and NF-kappaB pathways.
Penna G; Fibbi B; Amuchastegui S; Corsiero E; Laverny G; Silvestrini E; Chavalmane A; Morelli A; Sarchielli E; Vannelli GB; Gacci M; Colli E; Maggi M; Adorini L
Prostate; 2009 Apr; 69(5):480-93. PubMed ID: 19107880
[TBL] [Abstract][Full Text] [Related]
19. BXL-628, a vitamin D receptor agonist effective in benign prostatic hyperplasia treatment, prevents RhoA activation and inhibits RhoA/Rho kinase signaling in rat and human bladder.
Morelli A; Vignozzi L; Filippi S; Vannelli GB; Ambrosini S; Mancina R; Crescioli C; Donati S; Fibbi B; Colli E; Adorini L; Maggi M
Prostate; 2007 Feb; 67(3):234-47. PubMed ID: 17163492
[TBL] [Abstract][Full Text] [Related]
20. Nitric oxide inhibits endothelin-1-induced neonatal cardiomyocyte hypertrophy via a RhoA-ROCK-dependent pathway.
Hunter JC; Zeidan A; Javadov S; Kilić A; Rajapurohitam V; Karmazyn M
J Mol Cell Cardiol; 2009 Dec; 47(6):810-8. PubMed ID: 19799911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
